Search Results

Displaying Results 101-125 of 449 "'ASC'"

Jul 05, 2026, 20:10 ET 歌禮向美國FDA遞交兩項治療肥胖症的IND申請:多肽胰澱素受體激動劑月注射劑ASC36以及ASC36聯合多肽GLP-1R/GIPR激動劑ASC35的ASC36_35復方月注射劑

ASC36_35 FDC是每月一次皮下注射的ASC36和ASC35的復方制劑,有望成為靶向胰澱素受體、GLP-1R和GIPR這三個已驗證的靶點的同類首創(first-in-class)候選藥物。-  在頭對頭飲食誘導肥胖(DIO)大鼠研究中,ASC36_35 FDC的減重效果較eloralintide聯合替爾泊肽相對提升約51%。- 

More news about: 歌禮製藥有限公司


Jul 02, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Veritone, Inc. of Class Action Lawsuit and Upcoming Deadlines - VERI

three and twelve months ended December 31, 2025 because it is currently finalizing its accounting determination of certain revenue transactions under ASC 606." On this news, Veritone's stock price fell $0.77 per share, or 29.5%, to close at $1.84 per share on March 27, 2026. Then, on April

More news about: Pomerantz LLP


Jul 01, 2026, 09:13 ET OrthAlign Announces First Cases with Lantern® ASC System, Eliminating the Economic Barriers of Robotic Technology

performed on June 30th by Dr. Zane Uhland, orthopedic surgeon and ASC owner, who performed 6 total knee procedures with Lantern ASC in a high-efficiency outpatient setting in under 4 hours."As both a surgeon and an ASC owner, I've always believed that technology should enhance patient care

More news about: OrthAlign


Jul 01, 2026, 08:31 ET Valet Health, OnDoc.ai, and ViewMedica Launch CarePath PX to Unify Delivery of Automated, Provider-Branded Patient Education for Advanced Care

staff," added John Rioux, CEO of OnDoc.ai. "Every patient feels informed and connected to their provider at every stage of their care journey."For ASC administrators and hospital outpatient program leaders, the platform delivers a critical capability: closed-loop reporting that links patient engagement

More news about: Valet Health


Jul 01, 2026, 06:00 ET NetRise Announces Partner-Led Managed Software Supply Chain Risk Management Offering for the Federal Market

trusted partner who can operationalize those capabilities inside their environments," said Sarn Gabriel Bien-Aime, Founder & CEO, Asc3nd Technologies Group.  "Asc3nd has built our federal practice around closing that visibility gap, and NetRise gives our customers the binary-derived evidence and provenance

More news about: NetRise


Jun 30, 2026, 07:30 ET Phoenix Merchant Partners and Texas Capital Alternative Asset Management Announce Strategic Relationship to Serve the Core Middle Market

www.texascapital.com)Media & Investor Relations ContactsPhoenix Merchant Partners Media RelationsASC Advisors, Taylor Ingraham Email:[email protected]

More news about: Phoenix Merchant Partners


Jun 29, 2026, 16:00 ET Surgical Information Systems Welcomes Tim O'Brien as Chief Executive Officer

what matters most: delivering exceptional patient care and outcomes.Recognized as the No. 1 ASC EHR vendor by Black Book for 11 consecutive years and honored with the Best in KLAS Award for ASC Solutions in 2026, 2025, 2023, and 2022, SIS remains the trusted choice for surgical providers seeking

More news about: SURGICAL INFORMATION SYSTEMS


Jun 29, 2026, 08:49 ET DISC Surgery Center at Palm Beach Opens with Elite Team of Spine, Total Joint and Orthopedic Specialists

surgical technologies. At 15,618 square feet, this ambulatory surgery center (ASC) houses three operating suites, seven preoperative rooms and five PACU bays, as well as a full-service musculoskeletal clinic with three exam rooms. The ASC, now fully licensed in the state of Florida, is officially open."There

More news about: DISC Surgery Center


Jun 26, 2026, 15:30 ET EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Veritone (VERI) Investors of Securities Class Action Deadline on July 20, 2026

explained that the range in expected revenue was because it was "currently finalizing its accounting determination for certain revenue transactions under ASC 606."On this news, Veritone's stock price fell $0.77, or 29.5%, to close at $1.84 per share on March 27, 2026, thereby injuring investors.Then,

More news about: Faruqi & Faruqi, LLP


Jun 25, 2026, 10:25 ET USOP Appoints Dean Brown Regional Director of ASC Operations

physician partners inside them. That kind of experience is exactly what we need as our ASC platform continues to mature."Experienced ASC LeadershipBrown joins USOP with more than two decades of ASC leadership experience, including extensive work in orthopedic surgery center operations,

More news about: U.S. Orthopaedic Partners


Jun 25, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Veritone, Inc. of Class Action Lawsuit and Upcoming Deadlines - VERI

three and twelve months ended December 31, 2025 because it is currently finalizing its accounting determination of certain revenue transactions under ASC 606." On this news, Veritone's stock price fell $0.77 per share, or 29.5%, to close at $1.84 per share on March 27, 2026.Then, on April

More news about: Pomerantz LLP


Jun 24, 2026, 10:09 ET Lost Money on Veritone, Inc. (VERI)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

by $1.5 million (246% of reported amount)Revenue was misclassified in transactions where Veritone acted as an agent, not a principal, under ASC 606The Company had been evaluating a $13.0 million non-monetary software transaction with a fair value range as wide as $0.4 million to $11.3

More news about: Levi & Korsinsky, LLP


Jun 23, 2026, 08:17 ET Ambulatory Surgical Centres Poised for Sustained Growth as Healthcare Delivery Continues to Shift Beyond the Hospital

growth opportunities reshaping healthcare delivery worldwide. Driven by rising demand for efficient, cost-effective, and patient-centric care, the global ASC market is forecast to grow by more than 30% between 2024 and 2029. While ASCs have long played an important role in outpatient care, Frost &

More news about: Frost & Sullivan


Jun 23, 2026, 08:17 ET Ambulatory Surgical Centres Poised for Sustained Growth as Healthcare Delivery Continues to Shift Beyond the Hospital

growth opportunities reshaping healthcare delivery worldwide. Driven by rising demand for efficient, cost-effective, and patient-centric care, the global ASC market is forecast to grow by more than 30% between 2024 and 2029. While ASCs have long played an important role in outpatient care, Frost &

More news about: Frost & Sullivan


Jun 23, 2026, 06:10 ET Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity

GLP-1R/GIPR dual peptide agonist and ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, ASC39, an eloralintide-like potent and amylin-selective oral small molecule amylin receptor agonist, and ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30 (GLP-1RA) and ASC39 (amylin RA), for chronic weight management.

More news about: Ascletis Pharma Inc.


Jun 23, 2026, 06:10 ET 歌禮宣佈其每月一次皮下注射GLP-1R/GIPR雙靶點激動劑多肽ASC35治療肥胖症的I期研究IND獲美國FDA批准

香港2026年6月23日 /美通社/ -- 歌禮製藥有限公司(香港聯交所代碼:1672,簡稱「歌禮」)今日宣佈,其近期已獲得美國食品藥品監督管理局(FDA)對其ASC35的I期研究的新藥臨床試驗(IND)批准。ASC35是一款有望成為同類最佳(best-in-class)、每月一次皮下注射的GLP-1受體(GLP-1R)/GIP受體(GIPR)雙靶點激動劑多肽,用於治療肥胖症。

More news about: 歌禮製藥有限公司


Jun 22, 2026, 10:31 ET Hematopoietic Stem Cell Transplantation Market Landscape to Evolve at a CAGR of 12.4% During the Forecast Period (2026-2036) as Novel Therapies and Expanding Patient Eligibility Drive Growth | DelveInsight

CSL Behring, Equillium, Biocon, MaaT Pharma, REGiMMUNE, ReAlta Life Sciences, Ono Pharmaceutical (Deciphera Pharmaceuticals), Medsenic, BioSenic, ASC Therapeutics, Cynata Therapeutics, Evive Biotech (Yifan Pharmaceutical), Ironwood, medac, and others.About DelveInsightDelveInsight

More news about: DelveInsight Business Research, LLP


Jun 18, 2026, 11:24 ET Hassan Usmani, D.P.M., Becomes First in the State of Indiana to Use Arthrex Plate and Medial Capsule Repair System for Patients with Bunions

the newest generation of the Arthrex Lapidus I-Beam and BunionBrace and performed the surgery at Lakeshore Surgicare, an ambulatory surgery center (ASC) located in Chesterton, Indiana."With the Arthrex Lapidus I-Beam Plate and BunionBrace, we offer patients a minimally invasive, joint-preserving

More news about: Lakeshore Bone & Joint Institute


Jun 18, 2026, 10:09 ET SueWallSt Reminds Veritone, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 20, 2026 - VERI

prospectus failed to disclose that Veritone had misclassified revenue and costs in transactions where it acted as an agent rather than a principal under ASC 606Accounts receivable incorporated into the offering documents were allegedly overstated by $0.9 millionThe Company's

More news about: SueWallSt.com


Jun 18, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Veritone, Inc. of Class Action Lawsuit and Upcoming Deadlines - VERI

three and twelve months ended December 31, 2025 because it is currently finalizing its accounting determination of certain revenue transactions under ASC 606." On this news, Veritone's stock price fell $0.77 per share, or 29.5%, to close at $1.84 per share on March 27, 2026. Then, on April

More news about: Pomerantz LLP


Jun 17, 2026, 10:15 ET VERI Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Veritone, Inc. Securities Lawsuit - Contact Levi & Korsinsky

individual defendants directed or had the authority to direct Veritone's day-to-day operations, including oversight of revenue recognition practices under ASC 606 that are now at the center of the restatement. The action contends their control extended to the Company's communications with the investing public,

More news about: Levi & Korsinsky, LLP


Jun 17, 2026, 08:45 ET Surgical Information Systems Launches SIS Scribe to Accelerate ASC Revenue Cycles with AI Transcription

"The launch of SIS Scribe is a significant milestone in our mission to deliver a smarter, more tech-enabled approach to ASC facility management."Transformative Impact on ASC Operations"SIS Scribe directly addresses one of the most persistent challenges in the ambulatory surgery space

More news about: SURGICAL INFORMATION SYSTEMS


Jun 16, 2026, 16:35 ET Ardmore Shipping Exercises Newbuilding Options

HAMILTON, Bermuda, June 16, 2026 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced it has exercised the options for two additional 40,500 dwt Handysize product/chemical tankers to be built

More news about: Ardmore Shipping Corporation


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.